Skip to main content
. 2025 Sep 25;12(10):380. doi: 10.3390/jcdd12100380
ACE-I Angiotensin-Converting Enzyme Inhibitor
AL Light-Chain Amyloidosis
AMY-CCM Amyloidosis–Cardiac Contractility Modulation Registry
ARB Angiotensin Receptor Blocker
ARNI Angiotensin Receptor–Neprilysin Inhibitor
ATTR Transthyretin
ATTR-CM Transthyretin Cardiac Amyloidosis
BB Beta-Blocker
BMI Body Mass Index
CABG Coronary Artery Bypass Grafting
CaMKII Calcium/Calmodulin-Dependent Protein Kinase II
CCB Calcium Channel Blocker
CCM Cardiac Contractility Modulation
CMR Cardiac Magnetic Resonance
CRT Cardiac Resynchronization Therapy
ECG Electrocardiogram
EDV End-Diastolic Volume
EF Ejection Fraction
eGFR Estimated Glomerular Filtration Rate
ESV End-Systolic Volume
H Hereditary
HF Heart Failure
HSP70 Heat Shock Protein 70
ICD Implantable Cardioverter-Defibrillator
IQR Interquartile Range
KCCQ Kansas City Cardiomyopathy Questionnaire
MAPK Mitogen-Activated Protein Kinase
MRA Mineralocorticoid Receptor Antagonist
NT-proBNP N-terminal pro-B-type Natriuretic Peptide
NYHA New York Heart Association (Functional Class)
OMT Optimal Medical Therapy
PCI Percutaneous Coronary Intervention
PKA Protein Kinase A
PKB Protein Kinase B
PLB Phospholamban
ROS Reactive Oxygen Species
RyR2 Ryanodine Receptor 2
SERCA Sarcoplasmic/Endoplasmic Reticulum Calcium ATPase
SGLT2-i Sodium-Glucose Cotransporter-2 Inhibitor
TAPSE Tricuspid Annular Plane Systolic Excursion
TTR Transthyretin Protein
WHF Worsening Heart Failure
WT Wild-Type
α-MHC Alpha-Myosin Heavy Chain